| Intra-articular treatment of knee osteoarthritis: from anti-inflammatories to products of regenerative medicine MM Richards, JS Maxwell, L Weng, MG Angelos, J Golzarian The Physician and sportsmedicine 44 (2), 101-108, 2016 | 197 | 2016 |
| Characterization of umbilical cord blood–derived late outgrowth endothelial progenitor cells exposed to laminar shear stress MA Brown, CS Wallace, M Angelos, GA Truskey Tissue Engineering Part A 15 (11), 3575-3587, 2009 | 110 | 2009 |
| Pluripotent stem cell applications for regenerative medicine MG Angelos, DS Kaufman Current opinion in organ transplantation 20 (6), 663-670, 2015 | 67 | 2015 |
| Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells MG Angelos, PN Ruh, BR Webber, RH Blum, CD Ryan, L Bendzick, ... Blood, The Journal of the American Society of Hematology 129 (26), 3428-3439, 2017 | 63 | 2017 |
| Dynamic adhesion of umbilical cord blood endothelial progenitor cells under laminar shear stress MG Angelos, MA Brown, LL Satterwhite, VW Levering, NT Shaked, ... Biophysical journal 99 (11), 3545-3554, 2010 | 45 | 2010 |
| Single cell resolution of human hematoendothelial cells defines transcriptional signatures of hemogenic endothelium MG Angelos, JE Abrahante, RH Blum, DS Kaufman Stem Cells 36 (2), 206-217, 2018 | 30 | 2018 |
| Advances in the role of the aryl hydrocarbon receptor to regulate early hematopoietic development MG Angelos, DS Kaufman Current opinion in hematology 25 (4), 273-278, 2018 | 18 | 2018 |
| A phase 1, first-in-human (FIH) study of the anti-HER2 CAR macrophage CT-0508 in subjects with HER2 overexpressing solid tumors. KA Reiss, Y Yuan, NT Ueno, ML Johnson, S Gill, EC Dees, J Chao, ... Journal of Clinical Oncology 40 (16_suppl), 2533-2533, 2022 | 10 | 2022 |
| A phase 1, first-in-human (FIH) study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in participants with … KA Reiss, Y Yuan, NT Ueno, ML Johnson, S Gill, EC Dees, J Chao, ... Journal of Clinical Oncology 40 (16_suppl), TPS2677-TPS2677, 2022 | 5 | 2022 |
| Advances and personalized approaches in the frontline treatment of T-cell lymphomas MG Angelos, HJ Ballard, SK Barta Journal of Personalized Medicine 12 (2), 267, 2022 | 4 | 2022 |
| Sequence specific effects on DNA and cell damage with the PARP inhibitor olaparib (AZD2281) and carboplatin. JL Hays, G Kim, J Mariani, RF Murphy, M Angelos, A McCollum, J Lu, ... Journal of Clinical Oncology 29 (15_suppl), 5025-5025, 2011 | 4 | 2011 |
| 633 a phase 1, first in human (FIH) study of autologous macrophages containing an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2 overexpressing solid tumors K Reiss, N Ueno, Y Yuan, M Johnson, EC Dees, J Chao, M Angelos, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 3 | 2022 |
| A novel function of WW domain binding protein 2 (WBP2) in regulating cytoskeletal function and cellular division through binding to co-chaperone BAG3 AK McCollum, MG Angelos, AD Fischione, M Mineo, EC Kohn Cancer Research 72 (8_Supplement), 2032-2032, 2012 | 3 | 2012 |
| Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on-and off-rates against non-Hodgkin … Y Zhang, RP Patel, KH Kim, H Cho, JC Jo, SH Jeong, SY Oh, YS Choi, ... Molecular cancer 22 (1), 200, 2023 | 1 | 2023 |
| Progress and pitfalls of chimeric antigen receptor T cell immunotherapy against T cell malignancies MG Angelos, RP Patel, M Ruella, SK Barta Transplantation and Cellular Therapy, 2023 | 1 | 2023 |
| Hematopoietic stem/progenitor cells and engineering: a phase 1, first in human (FIH) study of adenovirally transduced autologous macrophages engineered to contain an ANTI-HER2 … Y Abdou, Y Yuan, NT Ueno, EC Dees, J Chao, N Grover, M Angelos, ... Cytotherapy 24 (5), S26-S27, 2022 | 1 | 2022 |
| Transcriptional and Functional Activity of Canine Hemangiosarcoma to Support Hematopoiesis Demonstrate Bone Marrow Nurse Cell Ontogeny JH Kim, AJ Schulte, AL Sarver, MG Angelos, AM Frantz, CL Forster, ... BioRxiv, 2021.05. 21.445198, 2021 | 1 | 2021 |
| Pluripotent stem cells and gene therapy MG Angelos, F Kidwai, DS Kaufman Translating Gene Therapy to the Clinic, 11-26, 2015 | 1 | 2015 |
| Fratricide-Resistant Anti-CD2 Chimeric Antigen Receptor T-Cells with Endogenous CD2 Knockout Are Highly Effective Against T-Cell Neoplasms MG Angelos, RP Patel, YH Chiang, W Xie, R Pajarillo, CE Shaw, E Singh, ... Blood 142, 885, 2023 | | 2023 |
| Disinhibition of T Cell Activation Via CD5 Knockout Is a Universal Strategy to Enhance Adoptive T Cell Immunotherapies RP Patel, G Ghilardi, Y Zhang, P Guruprasad, MG Angelos, R Pajarillo, ... Blood 142, 102, 2023 | | 2023 |
